These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 8144213

  • 41. Angiotensin and bradykinin peptides in rats with myocardial infarction.
    Duncan AM, Burrell LM, Kladis A, Campbell DJ.
    J Card Fail; 1997 Mar; 3(1):41-52. PubMed ID: 9110254
    [Abstract] [Full Text] [Related]

  • 42. Renal amylin binding in normotensive and hypertensive rats: effects of angiotensin converting enzyme inhibition with perindopril.
    Cao Z, Wookey PJ, Wu LL, Voskuil M, van Geenen RC, Cooper ME.
    J Hypertens; 1997 Nov; 15(11):1245-52. PubMed ID: 9383173
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure.
    Su JB, Barbe F, Crozatier B, Campbell DJ, Hittinger L.
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):700-10. PubMed ID: 10547087
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Cultured myofibroblasts generate angiotensin peptides de novo.
    Katwa LC, Campbell SE, Tyagi SC, Lee SJ, Cicila GT, Weber KT.
    J Mol Cell Cardiol; 1997 May; 29(5):1375-86. PubMed ID: 9201623
    [Abstract] [Full Text] [Related]

  • 50. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C, Grima M, Michel B, Barthelmebs M, Imbs JL.
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J, Ura N, Yoshida H, Shinshi Y, Sasaki H, Hyakkoku M, Taniguchi S, Shimamoto K.
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats.
    Campbell DJ, Duncan AM, Kladis A, Harrap SB.
    Hypertension; 1995 May; 25(5):928-34. PubMed ID: 7737729
    [Abstract] [Full Text] [Related]

  • 57. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, Luzzana E, Colosio V, Bertani T, Remuzzi G.
    Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
    [Abstract] [Full Text] [Related]

  • 58. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II.
    Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Remme WJ, Jacob H, Dzau VJ.
    Circ Res; 1993 Feb; 72(2):312-8. PubMed ID: 8380358
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.